ArticleThe AAPS journal2023

Population-Based Pharmacodynamic Modeling of Omalizumab in Pediatric Patients with Moderate to Severe Persistent Inadequately Controlled Allergic Asthma.

Rui Zhu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.